A groundbreaking trial explores personalized endocrine therapy for early-stage breast cancer, aiming to reduce chemotherapy's ...

Marketing of MIMEDX’s Leading Placental Allograft Portfolio and Vaporox’s Vaporous Hyperoxia Treatment DeviceMARIETTA, Ga., ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the launch of the ...

Hospitalists working in behavioral health centers face unique challenges, including limited resources and complex patient ...

ABA therapy centers in Middle River and Owings Mills expand access to high-quality, early intervention services for young children with autismSILVER SPRING, Md., July 31, 2025 (GLOBE NEWSWIRE) -- ...

On a cold fall day sometime during the height of COVID, our family received the unexpected gift of new friendship. A lovely family made the bold ...

Allogene Therapeutics has reported a patient death tied to its anti-CD52 monoclonal antibody used for lymphodepletion in its ...

Sanofi’s Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma  Approval based on GMMG-HD7 phase 3 study demonstrating that Sarclisa with VRd induction ...

Company gatherings are trading stuffy rooms and PowerPoints for plant-based meals, mocktails and mindfulness — all in pursuit of healthier, more engaged teams and a better return on human capital.

The company continues to strive toward higher margins, which may help earnings grow faster than sales, on a durable basis, especially if its new CEO introduces some of his former employer's (Danaher's ...

Having released six studio albums as a successful solo artist, Van Etten’s lyricised, open-chested honesty has touched ...

Bristol-Myers Squibb Company beats revenue forecasts & raises 2025 guidance. Click for key BMY catalysts, risks, and outlook ...